rs138399600
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_014727.3(KMT2B):c.364-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00258 in 1,565,752 control chromosomes in the GnomAD database, including 148 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0048 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 126 hom. )
Consequence
KMT2B
NM_014727.3 intron
NM_014727.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0540
Publications
0 publications found
Genes affected
KMT2B (HGNC:15840): (lysine methyltransferase 2B) This gene encodes a protein which contains multiple domains including a CXXC zinc finger, three PHD zinc fingers, two FY-rich domains, and a SET (suppressor of variegation, enhancer of zeste, and trithorax) domain. The SET domain is a conserved C-terminal domain that characterizes proteins of the MLL (mixed-lineage leukemia) family. This gene is ubiquitously expressed in adult tissues. It is also amplified in solid tumor cell lines, and may be involved in human cancer. Two alternatively spliced transcript variants encoding distinct isoforms have been reported for this gene, however, the full length nature of the shorter transcript is not known. [provided by RefSeq, Jul 2008]
KMT2B Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorder with motor featuresInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dystonia 28, childhood-onsetInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual developmental disorder, autosomal dominant 68Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 19-35719453-C-T is Benign according to our data. Variant chr19-35719453-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0755 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2B | ENST00000420124.4 | c.364-16C>T | intron_variant | Intron 1 of 36 | 1 | NM_014727.3 | ENSP00000398837.2 | |||
| KMT2B | ENST00000673918.2 | c.364-16C>T | intron_variant | Intron 1 of 36 | ENSP00000501283.1 | |||||
| KMT2B | ENST00000687718.1 | n.364-331C>T | intron_variant | Intron 1 of 2 | ENSP00000510535.1 | |||||
| KMT2B | ENST00000692961.1 | n.364-16C>T | intron_variant | Intron 1 of 35 | ENSP00000509289.1 |
Frequencies
GnomAD3 genomes AF: 0.00482 AC: 733AN: 152176Hom.: 21 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
733
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0124 AC: 2225AN: 178846 AF XY: 0.00950 show subpopulations
GnomAD2 exomes
AF:
AC:
2225
AN:
178846
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00234 AC: 3307AN: 1413458Hom.: 126 Cov.: 30 AF XY: 0.00203 AC XY: 1422AN XY: 699236 show subpopulations
GnomAD4 exome
AF:
AC:
3307
AN:
1413458
Hom.:
Cov.:
30
AF XY:
AC XY:
1422
AN XY:
699236
show subpopulations
African (AFR)
AF:
AC:
18
AN:
32158
American (AMR)
AF:
AC:
2944
AN:
37838
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
25244
East Asian (EAS)
AF:
AC:
0
AN:
36948
South Asian (SAS)
AF:
AC:
0
AN:
80256
European-Finnish (FIN)
AF:
AC:
77
AN:
50370
Middle Eastern (MID)
AF:
AC:
0
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
98
AN:
1086306
Other (OTH)
AF:
AC:
165
AN:
58626
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
160
319
479
638
798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00482 AC: 734AN: 152294Hom.: 22 Cov.: 32 AF XY: 0.00525 AC XY: 391AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
734
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
391
AN XY:
74470
show subpopulations
African (AFR)
AF:
AC:
27
AN:
41554
American (AMR)
AF:
AC:
657
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
12
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21
AN:
68018
Other (OTH)
AF:
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 23, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.